Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187


Manipulation of human early T lymphopoiesis by coculture on human bone marrow stromal cells: potential utility for adoptive immunotherapy.

Liu B, Ohishi K, Orito Y, Nakamori Y, Nishikawa H, Ino K, Suzuki K, Matsumoto T, Masuya M, Hamada H, Mineno J, Ono R, Nosaka T, Shiku H, Katayama N.

Exp Hematol. 2013 Apr;41(4):367-76.e1. doi: 10.1016/j.exphem.2012.12.001. Epub 2012 Dec 17.


Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis.

Nakamori Y, Liu B, Ohishi K, Suzuki K, Ino K, Matsumoto T, Masuya M, Nishikawa H, Shiku H, Hamada H, Katayama N.

Br J Haematol. 2012 Jun;157(6):674-86. doi: 10.1111/j.1365-2141.2012.09109.x. Epub 2012 Mar 30.


T-lymphoid differentiation potential measured in vitro is higher in CD34+CD38-/lo hematopoietic stem cells from umbilical cord blood than from bone marrow and is an intrinsic property of the cells.

De Smedt M, Leclercq G, Vandekerckhove B, Kerre T, Taghon T, Plum J.

Haematologica. 2011 May;96(5):646-54. doi: 10.3324/haematol.2010.036343. Epub 2011 Feb 17.


Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells.

Yamaguchi M, Hirayama F, Kanai M, Sato N, Fukazawa K, Yamashita K, Sawada K, Koike T, Kuwabara M, Ikeda H, Ikebuchi K.

Exp Hematol. 2001 Feb;29(2):174-82.


In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.

Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.

Exp Hematol. 2000 Dec;28(12):1470-80.


Biomaterial-based notch signaling for the differentiation of hematopoietic stem cells into T cells.

Taqvi S, Dixit L, Roy K.

J Biomed Mater Res A. 2006 Dec 1;79(3):689-97. Erratum in: J Biomed Mater Res A. 2007 Apr;81(1):257-8.


Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling.

Zhao Y, Parkhurst MR, Zheng Z, Cohen CJ, Riley JP, Gattinoni L, Restifo NP, Rosenberg SA, Morgan RA.

Cancer Res. 2007 Mar 15;67(6):2425-9.


Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells.

Diaz-Solano D, Wittig O, Ayala-Grosso C, Pieruzzini R, Cardier JE.

Stem Cells Dev. 2012 Nov 20;21(17):3187-96. doi: 10.1089/scd.2012.0084. Epub 2012 May 18.


Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.

Yu H, Fehniger TA, Fuchshuber P, Thiel KS, Vivier E, Carson WE, Caligiuri MA.

Blood. 1998 Nov 15;92(10):3647-57.


A human thymic epithelial cell culture system for the promotion of lymphopoiesis from hematopoietic stem cells.

Beaudette-Zlatanova BC, Knight KL, Zhang S, Stiff PJ, Zúñiga-Pflücker JC, Le PT.

Exp Hematol. 2011 May;39(5):570-9. doi: 10.1016/j.exphem.2011.01.014. Epub 2011 Feb 4.


T-cell development, doing it in a dish.

Schmitt TM, Zúñiga-Pflücker JC.

Immunol Rev. 2006 Feb;209:95-102. Review.


CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential.

Schmitt C, Ktorza S, Sarun S, Blanc C, De Jong R, Debre P.

Blood. 1993 Dec 15;82(12):3675-85.


[Long-term expansion of T cell progenitors by JAK3 gene transduced primitive hematopoietic cells in vitro].

Zhao SM, Gu XC, Chang NB, Xu XD, Peng MT.

Zhonghua Yi Xue Za Zhi. 2006 Jun 27;86(24):1701-5. Chinese.


Mesenchymal stem cells promote a primitive phenotype CD34+c-kit+ in human cord blood-derived hematopoietic stem cells during ex vivo expansion.

Rodríguez-Pardo VM, Vernot JP.

Cell Mol Biol Lett. 2013 Mar;18(1):11-33. doi: 10.2478/s11658-012-0036-1. Epub 2012 Oct 27.


Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes.

Mohtashami M, Shah DK, Nakase H, Kianizad K, Petrie HT, Zúñiga-Pflücker JC.

J Immunol. 2010 Jul 15;185(2):867-76. doi: 10.4049/jimmunol.1000782. Epub 2010 Jun 14. Erratum in: J Immunol. 2010 Sep 15;185(6):3777-8.


Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro.

La Motte-Mohs RN, Herer E, Zúñiga-Pflücker JC.

Blood. 2005 Feb 15;105(4):1431-9. Epub 2004 Oct 19.

Supplemental Content

Support Center